BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,529 | +1047.5% | 130 | +1344.4% | 0.00% | – |
| Q2 2023 | $569 | +40.5% | 9 | 0.0% | 0.00% | – |
| Q1 2023 | $405 | – | 9 | +50.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 6 | -71.4% | 0.00% | – |
| Q1 2022 | $1,000 | -93.8% | 21 | -85.8% | 0.00% | -100.0% |
| Q4 2021 | $16,000 | +6.7% | 148 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | +650.0% | 150 | +614.3% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 21 | -34.4% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 32 | +52.4% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 21 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -38.2% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 34 | +54.5% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | +100.0% | 22 | +37.5% | 0.00% | – |
| Q2 2018 | $1,000 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |